SC
GH icon

Savant Capital’s Guardant Health GH Stock Holding History

Savant Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
+2,082
New +$226K ﹤0.01% 1473

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Savant Capital's GH Position: Q2 2026 in Review

Savant Capital opened a new position in Guardant Health (GH) in Q2 2026: 2,082 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #1473 among its holdings.

597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Savant Capital held 2,082 shares of Guardant Health worth $315K as of Q2 2026.
  • Guardant Health was a new Savant Capital position in Q2 2026.
  • Guardant Health made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1473 holding.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.